David Young, Chief Scientific Officer at QUESTCOR PHARMACEUTICALS INC (QCOR), sold 6,000 shares at $62.65 ($374K) on 2014-03-14, disclosed to the SEC on 2014-03-18.
Scheduled sale ($374k) by Chief Scientific Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $61.78 | 2,587 | $160K | 42.8% |
| 2 | $62.65 | 3,413 | $214K | 57.2% |
| Total | $62.27 avg | 6,000 | $374K | 100% |
| Filing → |
| PCSA | BUY | 2026-06-01 | $5K | — | Filing → |
| PCSA | BUY | 2026-05-19 | $5K | — | Filing → |
| PCSA | BUY | 2026-05-01 | $5K | — | Filing → |